<- Go Home
ArthroCare Corporation
ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products based on its Coblation technology in the Americas and internationally. It offers sports medicine products, including Coblation Wands that features disposable energy-based surgical wands for single patient use to treat shoulder, knee, hip, foot, ankle, elbow, and wrist injuries; and soft-tissue fixation products, such as knotless and traditional anchors for rotator cuff and labrum repairs in the shoulder and hip; screws for ligament reconstruction in the knee; and arthroscopic suture passers, as well as reusable hand-held instruments, procedural kits, and accessories. The company also provides ear nose and throat products consisting of suction wands, channeling wands, and excision wands; ENTact septal stapler for reattaching nasal mucosal flaps; SerpENT articulating instruments, which include cutting and grasping tools; and Ventera sinus dilation systems. The company provides SpineWand devices to treat soft tissue conditions in the spine; Plasma Disc Decompression SpineWands for treating contained herniated discs; Cavity SpineWand to reduce the size of malignant lesions in the vertebrae of patients suffering from spinal compression fractures; and WoundWand for wound debridement and wound cleansing by removal of necrotic tissue. The company sells its products to surgeons and specialized medical professionals through sales representatives, and independent sales agents and distributors. The company was founded in 1993 and is headquartered in Austin, Texas. As of May 29, 2014, ArthroCare Corporation operates as a subsidiary of Smith & Nephew plc.
Market Cap
$1.7B
Volume
235.2K
Cash and Equivalents
$191.0M
EBITDA
$87.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$265.3M
Profit Margin
69.51%
52 Week High
$49.95
52 Week Low
$31.56
Dividend
N/A
Price / Book Value
3.36
Price / Earnings
110.44
Price / Tangible Book Value
5.27
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$73.7M
Return on Equity
4.40%
Return on Assets
8.38
Cash and Short Term Investments
$191.0M
Debt
N/A
Equity
$498.1M
Revenue
$381.7M
Unlevered FCF
$35.3M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium